Promising Research on ALS & Lunasin
ALS, or amyotrophic lateral sclerosis, is a cruel, terminal neurodegenerative disease that slowly but surely causes those afflicted to lose all major muscle control. It is difficult to diagnose, difficult to treat, and difficult to cope with.
In recent months, niche research has begun to surface that may point toward improved patient responses to ALS. Results from further studies still in progress1 are awaited with bated breath, but the anecdotal evidence that some ALS patients have provided suggests that the lunasin peptide supports the body’s natural defensive systems, potentially promoting a higher quality of life in ALS patients2.